Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-050220
Filing Date
2015-02-13
Accepted
2015-02-13 16:44:58
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d831773d10k.htm 10-K 781400
2 CODE OF ETHICAL CONDUCT d831773dex14.htm EX-14 11866
3 CERTIFICATION d831773dex311.htm EX-31.1 8419
4 CERTIFICATION d831773dex312.htm EX-31.2 8247
5 CERTIFICATION d831773dex321.htm EX-32.1 3185
6 CERTIFICATION d831773dex322.htm EX-32.2 3192
  Complete submission text file 0001193125-15-050220.txt   3919054

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT hppi-20141231.xml EX-101.INS 324290
8 XBRL TAXONOMY EXTENSION SCHEMA hppi-20141231.xsd EX-101.SCH 42888
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20141231_cal.xml EX-101.CAL 35936
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20141231_def.xml EX-101.DEF 157690
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20141231_lab.xml EX-101.LAB 324923
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20141231_pre.xml EX-101.PRE 224330
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13467 | Film No.: 15615582
SIC: 8731 Services-Commercial Physical & Biological Research